DisclosurePeptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.

The compound database

Peptide Databasepage 8

264 therapeutic peptides with research summaries, clinical findings, and regulatory status. Every claim is cited.

FDA-approved
90
FDA-approved
Awaiting FDA
8
Awaiting FDA
No lawful pathway
166
No lawful pathway
253–264 of 264
  1. 253

    Follitropin Alfa (Gonal-F)

    Follitropin alfa is a recombinant human follicle-stimulating hormone produced in Chinese hamster ovary cells, a heterodimeric glycoprotein of an alpha and a…

    Reproductive · FDA Approved · Subcutaneous injection

    FDA-approved
  2. 254

    Menotropin (Menopur)

    Menotropin is a purified preparation of human menopausal gonadotropins extracted from the urine of postmenopausal women, containing both follicle-stimulating…

    Reproductive · FDA Approved · Subcutaneous injection, Intramuscular injection

    FDA-approved
  3. 255

    Corifollitropin Alfa (Elonva)

    Corifollitropin alfa is a long-acting recombinant FSH analogue created by fusing the C-terminal peptide of the hCG beta subunit to the FSH beta chain. In…

    Reproductive · In Clinical Trials · Subcutaneous injection

    No lawful pathway
  4. 256

    Cetrorelix (Cetrotide) Analog

    Cetrorelix is a synthetic decapeptide analogue of gonadotropin-releasing hormone that acts as a competitive GnRH receptor antagonist. By blocking pituitary…

    Reproductive · FDA Approved · Subcutaneous injection

    FDA-approved
  5. 257

    Peginesatide (Omontys)

    Peginesatide is a synthetic pegylated peptide-based erythropoiesis-stimulating agent that activates the erythropoietin receptor despite having no sequence…

    Hematology · FDA Approved · Intravenous, Subcutaneous injection

    FDA-approved
  6. 258

    Eltrombopag Peptide Mimetics

    Eltrombopag is an orally active, small-molecule, non-peptide thrombopoietin receptor agonist. Although it is not itself a peptide, it activates thrombopoietin…

    Hematology · FDA Approved · Oral

    FDA-approved
  7. 259

    Hepcidin

    Hepcidin is a 25-amino-acid peptide hormone secreted mainly by the liver in response to iron loading and inflammation, and it is the central regulator of…

    Hematology · In Clinical Trials · Subcutaneous injection

    No lawful pathway
  8. 260

    Thrombopoietin (TPO)

    Thrombopoietin is the endogenous glycoprotein hormone and principal physiologic regulator of megakaryocyte development and platelet production. It acts through…

    Hematology · Investigational · Subcutaneous injection, Intravenous

    No lawful pathway
  9. 261

    Gadopentetate Peptide Conjugates

    Gadopentetate peptide conjugates are experimental agents in which a gadolinium chelate is chemically linked to a targeting peptide so that MRI contrast is…

    Diagnostic · Research Phase · Intravenous

    No lawful pathway
  10. 262

    DOTATATE (Ga-68)

    Gallium-68 DOTATATE is a radiolabeled somatostatin analogue consisting of the octapeptide Tyr3-octreotate conjugated to the macrocyclic chelator DOTA, which…

    Diagnostic · FDA Approved · Intravenous

    FDA-approved
  11. 263

    Bombesin Analog Tracers

    Bombesin analogue tracers are synthetic peptides based on the amphibian peptide bombesin or its mammalian counterpart gastrin-releasing peptide, radiolabeled…

    Diagnostic · In Clinical Trials · Intravenous

    No lawful pathway
  12. 264

    RGD Peptide Tracers

    RGD peptide tracers are short synthetic peptides containing the arginine-glycine-aspartic acid sequence, which binds integrin receptors, in particular…

    Diagnostic · In Clinical Trials · Intravenous

    No lawful pathway

Index · all 264 peptides, A–Z

Important Medical Disclaimer

The information provided by the Peptide Association is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified, licensed healthcare provider before beginning any peptide therapy, supplement regimen, or making changes to an existing treatment plan.

Peptide therapies discussed on this site may not be FDA-approved for all listed indications. Individual results vary. The Peptide Association does not prescribe, diagnose, or treat any medical condition. Clinicians in our network are independently licensed practitioners; the Association checks each clinician’s NPI record but does not employ or directly supervise these clinicians.

© 2026 The Peptide Association. All rights reserved. Content on this site is protected under applicable intellectual property laws. The Peptide Association is not a medical practice.